Evista Tablet
Product Images NDC 0002-4184

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Evista (NDC 0002-4184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Evista 60mg 4184 Contain 013 02

Evista 60mg 4184 Contain 013 02
Evista 60 mg tablets packaging label by Eli Lilly and Company, containing 30 oral tablets of raloxifene hydrochloride. The label includes dosing warnings, storage instructions, and a barcode with the NDC number 0002-4184-30. The proprietary name Evista is highlighted prominently in red.*
FDA Label Image

Chemical Structure (Evista F001 V1)

Chemical Structure (Evista F001 V1)
Chemical structure of raloxifene hydrochloride, the active ingredient in Evista 60 mg tablets. The diagram shows the molecular structure with aromatic rings, hydroxyl groups, a thienyl ring, and a chloride ion representing the hydrochloride salt form.*
FDA Label Image

Figure 1 (Evista F002 V1)

Figure 1 (Evista F002 V1)
Two line graphs showing total hip mean percentage change from baseline over 24 months after randomization. The first graph compares Evista (Raloxifene hydrochloride) and placebo in all placebo and Evista subjects from two studies. The second graph compares CE (conjugated estrogens), Evista, and placebo in all placebo, Evista, and CE subjects among hysterectomized women. Both graphs depict percentage change on the Y-axis and months on the X-axis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.